INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹376 Cr | ₹294 Cr | ₹278 Cr | ₹315 Cr | ₹215 Cr |
What is the latest Total Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹376 Cr |
| Mar2024 | ₹294 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹315 Cr |
| Mar2021 | ₹215 Cr |
How is Total Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹376 Cr | 28.05 | |
| Mar2024 | ₹294 Cr | 5.92 | |
| Mar2023 | ₹278 Cr | -12.02 | |
| Mar2022 | ₹315 Cr | 46.63 | |
| Mar2021 | ₹215 Cr | - | |
Compare Total Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,859.6 Cr | 0.9% | -0.3% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 0.9% |
-0.3% |
-17.6% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses